News

Renovion

Apr 7, 20222 min read

Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...

Renovion

Nov 18, 20216 min read

A breathe-easier breakthrough

Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...

Renovion

Nov 8, 20213 min read

Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...

Renovion

Sep 21, 20213 min read

Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership

Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...

Renovion

Sep 4, 20202 min read

Renovion Announces Addition of Rich Mattingly to Board of Directors

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...

Renovion

Jul 9, 20202 min read

Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis

Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...

Renovion

Jun 18, 20203 min read

Completion of $8.1 Million Financing Round Enables Clinical Programs in Chronic Lung Diseases

Poised for pivotal lung transplant trial in U.S. Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of...

Renovion

Mar 1, 20182 min read

Dr. Robert Ryan joins Renovion, Inc. Board of Directors

Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung...

Renovion

Dec 20, 20172 min read

Renovion Elects Derek Winstanly as Chairman of Board of Directors

Renovion, Inc. ("Renovion"), an early stage drug development company targeting a novel treatment for lung transplant patients and other...